Wistar Fights COVID-19

Wistar Science. Wistar Legacy.

125 Years of Discovery

RotaTeq Approval

The FDA announced the licensing of the rotavirus vaccine developed collaboratively by Wistar, Children’s Hospital of Philadelphia, and Merck & Co., Inc. in the 1980s. The vaccine is sold as ROTATEQ® and is part of the recommended immunization schedule for infants 6 weeks to 32 weeks of age.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today